Low-Dose Acetylsalicylic Acid Treatment Modulates the Production of Cytokines and Improves Trophoblast Function in an in Vitro Model of Early-Onset Preeclampsia

American Journal of Pathology

Volumn 186, Issue 12, 2016, Pages 3217-3224

  Panagodage, Shanika ^a,b   Yong, Hannah E J ^a,b   Da Silva Costa, Fabricio ^a,b   Borg, Anthony J ^a   Kalionis, Bill ^a,b   Brennecke, Shaun P ^a,b   Murthi, Padma ^a,b,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BIRC8 PROTEIN; CASPASE 3; CXCL16 CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MESSENGER RNA; PLACENTAL GROWTH FACTOR; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; CYTOKINE; PGF PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW DRUG DOSE; PREECLAMPSIA; PRIORITY JOURNAL; SYNCYTIUM; TROPHOBLAST; CELL LINE; DRUG EFFECTS; GIANT CELL; METABOLISM; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SECRETION (PROCESS);

APOPTOSIS; ASPIRIN; CELL LINE; CYTOKINES; FEMALE; GIANT CELLS; HUMANS; PLACENTA; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS;

EID: 84995946055     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.08.010     Document Type: Article

References (36)

1. 1 Duley, L., Henderson-Smart, D.J., Meher, S., King, J.F., Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev, 2007, CD004659.
2. 2 Thornton, C., Dahlen, H., Korda, A., Hennessy, A., The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. Am J Obstet Gynecol 208 (2013), 476e1–476e5.
3. 3 WHO: The World Health Report 2005 - make every mother and child count. 2005, World Health Organization, Geneva, Switzerland.
4. 4 Eastabrook, G., Brown, M., Sargent, I., The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 25 (2011), 435–447.
5. 5 Bujold, E., Morency, A.M., Roberge, S., Lacasse, Y., Forest, J.C., Giguere, Y., Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 31 (2009), 818–826.
6. 6 Mello, G., Parretti, E., Fatini, C., Riviello, C., Gensini, F., Marchionni, M., Scarselli, G.F., Gensini, G.F., Abbate, R., Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45 (2005), 86–91.
7. 7 Wen, S.W., Chen, X.K., Rodger, M., White, R.R., Yang, Q., Smith, G.N., Sigal, R.J., Perkins, S.L., Walker, M.C., Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 198 (2008), 45e1–45e7.
8. 8 Kharb, S., Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 93 (2000), 37–39.
9. 9 Astrup, A., Calcium reduces risk of pre-eclampsia. Lancet 376 (2010), 1986–1987.
10. 10 Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J.C., Giguere, Y., Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116 (2010), 402–414.
11. 11 Roberge, S., Nicolaides, K.H., Demers, S., Villa, P., Bujold, E., Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 41 (2013), 491–499.
12. 12 Janes, S.L., Kyle, P.M., Redman, C., Goodall, A.H., Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemost 74 (1995), 1059–1063.
13. 13 Thorp, J.A., Walsh, S.W., Brath, P.C., Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am J Obstet Gynecol 159 (1988), 1381–1384.
14. 14 Wallenburg, H.C., Dekker, G.A., Makovitz, J.W., Rotmans, P., Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1 (1986), 1–3.
15. 15 Bose, P., Black, S., Kadyrov, M., Weissenborn, U., Neulen, J., Regan, L., Huppertz, B., Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 192 (2005), 23–30.
16. 16 Orendi, K., Gauster, M., Moser, G., Meiri, H., Huppertz, B., Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells. Placenta 31 (2010), 431–438.
17. 17 Han, C.S., Mulla, M.J., Brosens, J.J., Chamley, L.W., Paidas, M.J., Lockwood, C.J., Abrahams, V.M., Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol 118 (2011), 1021–1028.
18. 18 Pattillo, R.A., Gey, G.O., The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res 28 (1968), 1231–1236.
19. 19 Brown, M.A., Hague, W.M., Higgins, J., Lowe, S., McCowan, L., Oats, J., Peek, M.J., Rowan, J.A., Walters, B.N., Australasian Society for the Study of Hypertension in P. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 40 (2000), 133–138.
20. 20 Borg, A.J., Yong, H.E., Lappas, M., Degrelle, S.A., Keogh, R.J., Da Silva-Costa, F., Fournier, T., Abumaree, M., Keelan, J.A., Kalionis, B., Murthi, P., Decreased STAT3 in human idiopathic fetal growth restriction contributes to trophoblast dysfunction. Reproduction 149 (2015), 523–532.
21. 21 Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) method. Methods 25 (2001), 402–408.
22. 22 Yong, H.E.J., Murthi, P., Wong, M.H., Kalionis, B., Cartwright, J.E., Brennecke, S.P., Keogh, R.J., Effects of normal and high circulating concentrations of activin A on vascular endothelial cell functions and vasoactive factor production. Pregnancy Hypertens 5 (2015), 346–353.
23. 23 Huang, Y., Zhu, X.Y., Du, M.R., Li, D.J., Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy. J Immunol 180 (2008), 2367–2375.
24. 24 Huang, Y., Zhu, X.Y., Du, M.R., Wu, X., Wang, M.Y., Li, D.J., Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner. Hum Reprod 21 (2006), 1083–1091.
25. 25 Livingston, J.C., Chin, R., Haddad, B., McKinney, E.T., Ahokas, R., Sibai, B.M., Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 183 (2000), 1554–1557.
26. 26 Robinson, C.J., Johnson, D.D., Chang, E.Y., Armstrong, D.M., Wang, W., Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 195 (2006), 255–259.
27. 27 Torry, D.S., Wang, H.S., Wang, T.H., Caudle, M.R., Torry, R.J., Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 179 (1998), 1539–1544.
28. 28 Liu, Y., Zhao, Y., Yu, A., Zhao, B., Gao, Y., Niu, H., Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch Gynecol Obstet 292 (2015), 507–518.
29. 29 Poon, L.C., Nicolaides, K.H., Early prediction of preeclampsia. Obstet Gynecol Int, 2014, 2014, 297397.
30. 30 Weed, S., Bastek, J.A., Anton, L., Elovitz, M.A., Parry, S., Srinivas, S.K., Examining the correlation between placental and serum placenta growth factor in preeclampsia. Am J Obstet Gynecol 207 (2012), 140e1–140e6.
31. 31 Fujiwara, H., Tatsumi, K., Kosaka, K., Sato, Y., Higuchi, T., Yoshioka, S., Maeda, M., Ueda, M., Fujii, S., Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166). J Clin Endocrinol Metab 88 (2003), 3437–3443.
32. 32 Haouzi, D., Dechaud, H., Assou, S., Monzo, C., de Vos, J., Hamamah, S., Transcriptome analysis reveals dialogues between human trophectoderm and endometrial cells during the implantation period. Hum Reprod 26 (2011), 1440–1449.
33. 33 Abumaree, M.H., Al Jumah, M.A., Kalionis, B., Jawdat, D., Al Khaldi, A., AlTalabani, A.A., Knawy, B.A., Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev 9 (2013), 16–31.
34. 34 Darcy, K.M., Zangani, D., Wohlhueter, A.L., Huang, R.Y., Vaughan, M.M., Russell, J.A., Ip, M.M., Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells. J Histochem Cytochem 48 (2000), 63–80.
35. 35 Klonisch, T., Wolf, P., Hombach-Klonisch, S., Vogt, S., Kuechenhoff, A., Tetens, F., Fischer, B., Epidermal growth factor-like ligands and erbB genes in the peri-implantation rabbit uterus and blastocyst. Biol Reprod 64 (2001), 1835–1844.
36. 36 Levy, R., The role of apoptosis in preeclampsia. Isr Med Assoc J 7 (2005), 178–181.